The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.03BCNY
303.88M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue (TTM)
215.41MCNY
32.31M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
-27.67%
Updated Oct 24, 2026
Beta
0.4150x
vs all stocks
Updated Oct 24, 2026
52-Week Change
-32.63%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
2.03BCNY
303.88M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
2.04BCNY
306.56M · vs all stocks (USD)
Updated Oct 24, 2026
Price to Sales (TTM)
8.87x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.41×.Updated Oct 24, 2026
Price to Book (MRQ)
61.26x
Updated Oct 24, 2026
Enterprise to Revenue
9.49x
Updated Oct 24, 2026
Enterprise to EBITDA
-121.17x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 816.89×.Updated Oct 24, 2026
Gross Margin
19.24%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 31.65%.Updated Oct 24, 2026
Profit Margin
-27.67%
Updated Oct 24, 2026
Operating Margin
-52.02%
Updated Oct 24, 2026
Return on Assets (TTM)
-9.12%
Updated Oct 24, 2026
Return on Equity (TTM)
-92.58%
Updated Oct 24, 2026
Revenue (TTM)
215.41MCNY
32.31M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
4.50CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
-25.10%
Updated Oct 24, 2026
Gross Profit (TTM)
68.18MCNY
10.23M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
2.50MCNY
375.28K · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
-59.61MCNY
-8.94M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
-15.37%
Updated Oct 24, 2026
Operating Cash Flow (TTM)
-8.72MCNY
-1.31M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.00CNYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 24, 2026
Minority Interest (Equity)
1.25MCNYFY2025 · Dec 31, 2025
Revenue
228.10MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
158.27MCNYFY2025 · Dec 31, 2025
Gross Profit
69.84MCNYFY2025 · Dec 31, 2025
Operating Income
-47.71MCNY
-7.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-65.72MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-93.15KCNYFY2025 · Dec 31, 2025
Net Income
-65.62MCNYFY2025 · Dec 31, 2025
EBIT
-54.65MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
2.50MCNYFY2025 · Dec 31, 2025
Research & Development
50.03MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
8.72MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
729.38KCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
771.87KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.06MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.39CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.39CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
47.84MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
47.84MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-65.62MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.04MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-58.12MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-64.34MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
43.60MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-65.62MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
11.78MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-4.29MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
3.01KCNYFY2025 · Dec 31, 2025
Capital Expenditures
-6.22MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.11MCNYFY2025 · Dec 31, 2025
Sale of Investments
100.00KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-7.23MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
400.54MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-501.12MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.34MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-54.85MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-161.77MCNYFY2025 · Dec 31, 2025
Shares Outstanding
47.90MSharesUpdated Oct 24, 2026
Float Shares
37.87MSharesUpdated Oct 24, 2026
% Held by Insiders
28.12%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
3.96%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
25.92MCNY
3.89M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
0.5410CNYUpdated Oct 24, 2026
Total Debt (MRQ)
120.60MCNY
18.09M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
1.71x
Updated Oct 24, 2026
Current Ratio (MRQ)
0.5560x
Updated Oct 24, 2026
Book Value per Share (MRQ)
0.6510CNYUpdated Oct 24, 2026
Total Assets
343.68MCNY
51.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
154.77MCNYFY2025 · Dec 31, 2025
Total Liabilities
320.92MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
188.91MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
24.90MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
296.02MCNYFY2025 · Dec 31, 2025
Cash
47.93MCNYFY2025 · Dec 31, 2025
Cash Equivalents
582.00KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
48.51MCNYFY2025 · Dec 31, 2025
Accounts Receivable
66.89MCNYFY2025 · Dec 31, 2025
Inventory
1.05MCNYFY2025 · Dec 31, 2025
Accounts Payable
33.92MCNYFY2025 · Dec 31, 2025
Short-term Debt
170.02MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.54MCNYFY2025 · Dec 31, 2025
Long-term Debt
13.88MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.86MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
47.90MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.22BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
22.76MCNY
3.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
37.38CNYUpdated Oct 24, 2026
52-Week High
98.36CNYUpdated Oct 24, 2026
52-Week Change
-32.63%
vs all stocks
Updated Oct 24, 2026
Beta
0.4150x
vs all stocks
Updated Oct 24, 2026
50-Day MA
45.81CNYUpdated Oct 24, 2026
200-Day MA
62.47CNYUpdated Oct 24, 2026
Avg 10-Day Volume
1.65MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
1.68MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
-1.24CNYUpdated Oct 24, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score -1.54: distress zoneCritical
Altman Z-Score: -1.54
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Revenue is $32.31M, lower than 95% of all stocks globallySignificant